Tag: opioid safety

Effectively Communicating Medication Benefits and Risks – Are We Getting Better?

At a time of ever-ratcheting concern about the safety of our food and the appropriate, safe use of prescription drugs, the Food and Drug Administration (FDA) has moved forward in the past with a number of initiatives to better protect public health. Among them are efforts that are likely to impact how pharmaceutical companies help… Read more »

New Approaches to Combating Abuse of Opioids

Opioids play an important and omnipresent role in the treatment of moderate to severe acute and chronic pain. The fact of the matter is that in patients with acute pain, such as postoperative pain, opioids are utilized as the first-line treatment at least 98% of the time. Opioids are also recognized as the cornerstone of… Read more »

FDA Announces New Safety Measures for Extended-Release and Long-Acting Opioids

On September 10, 2013, the Food and Drug Administration (FDA) announced a number of changes that are intended to increase the safety of extended-release and long-acting (ER/LA) opioid medications. This announcement applies to all currently marketed ER/LA opioids, and implements two specific approaches to achieve the goal of combatting “the crisis of misuse, abuse, addiction, overdose, and death” according… Read more »

APS/AAPM Clinical Guidelines for Chronic Opioid Therapy in Patients with Noncancer Pain

The basis for the long-term use of opioids in the treatment of cancer pain has been fairly well established. Alternatively, a variety of controversies and differences of opinion have surrounded the use of opioid therapy when treating chronic noncancer pain. Issues range from the scientific basis for efficacy, safe and appropriate use, to health care… Read more »